A. Rhodes, L. E. Evans, and W. Alhazzani, Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock, Intensive Care Medicine, vol.43, issue.3, pp.304-377, 2016.

A. A. Udy, J. A. Roberts, and J. Lipman, Implications of augmented renal clearance in critically ill patients, Nature Reviews Nephrology, vol.7, pp.539-582, 2011.

C. Burdet, O. Pajot, and C. Couffignal, Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia, European Journal of Clinical pharmacology, vol.71, pp.75-83, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01079022

K. A. Rodvold, D. P. Nicolau, and T. P. Lodise, Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole, Antimicrobial Agents and Chemotherapy, vol.53, pp.3294-301, 2009.

J. P. Baptista, A. A. Udy, and E. Sousa, A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance, Critical Care, vol.15, p.139, 2011.

I. Helal, G. M. Fick-brosnahan, B. Reed-gitomer, and R. W. Schrier, Glomerular hyperfiltration: definitions, mechanisms and clinical implications, Nature reviews Nephrology, vol.8, pp.293-300, 2012.

J. A. Roberts, M. H. Abdul-aziz, and J. Lipman, Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions, Lancet Infectious Diseases, vol.14, pp.498-509, 2014.

A. Khwaja, KDIGO clinical practice guidelines for acute kidney injury, Nephron Clinical practice, vol.120, pp.179-84, 2012.

J. Goncalves-pereira and P. Povoa, Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams, Critical Care, vol.15, p.206, 2011.

, Évaluation de la fonction rénale et de la protéinurie pour le diagnostic de la maladie rénale chronique chez l'adulte. Recommandations pour la pratique clinique, Nephrologie & Therapeutique, vol.5, pp.302-307, 2009.

M. Shankar-hari, G. S. Phillips, and M. L. Levy, Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), Journal of the American Medical Association, vol.315, pp.775-87, 2016.

J. L. Vincent, Y. Sakr, and C. L. Sprung, Sepsis in European intensive care units: results of the SOAP study, Critical Care Medicine, vol.34, pp.344-53, 2006.

A. Suarez-de-la-rica, F. Gilsanz, and E. Maseda, Epidemiologic trends of sepsis in western countries, Annals of Translational Medicine, vol.4, p.325, 2016.

D. Annane, E. Bellissant, and J. M. Cavaillon, Septic shock, Lancet, vol.365, pp.63-78, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01414960

A. Kumar, D. Roberts, and K. E. Wood, Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock, Critical Care Medicine, vol.34, pp.1589-96, 2006.

O. Leroy, A. Meybeck, T. Escrivan, P. Devos, E. Kipnis et al., Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia, Intensive Care Medicine, vol.29, pp.2170-2173, 2003.

P. Montravers, R. Gauzit, C. Muller, J. P. Marmuse, A. Fichelle et al., Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy, Clinical Infectious Diseases, vol.23, pp.486-94, 1996.

E. H. Ibrahim, G. Sherman, S. Ward, V. J. Fraser, and M. H. Kollef, The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting, Chest, vol.118, pp.146-55, 2000.

M. H. Kollef, G. Sherman, S. Ward, and V. J. Fraser, Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients, Chest, vol.115, pp.462-74, 1999.

V. M. Ranieri, B. T. Thompson, and P. S. Barie, Drotrecogin alfa (activated) in adults with septic shock, New England Journal of Medicine, vol.366, pp.2055-64, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00865183

S. Finfer, D. R. Chittock, and S. Y. Su, Intensive versus conventional glucose control in critically ill patients, New England Journal of Medicine, vol.360, pp.1283-97, 2009.

C. L. Sprung, D. Annane, and D. Keh, Hydrocortisone therapy for patients with septic shock, New England Journal of Medicine, vol.358, pp.111-135, 2008.

R. Bellomo, A. Cass, and L. Cole, Intensity of continuous renal-replacement therapy in critically ill patients, New England Journal of Medicine, vol.361, pp.1627-1665, 2009.

R. D. Macarthur, M. Miller, and T. Albertson, Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial, Clinical Infectious Diseases, vol.38, pp.284-292, 2004.

A. Gous, J. Lipman, and J. Scribante, Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdominal sepsis, International Journal of Antimicrobial Agents, vol.26, pp.50-55, 2005.

A. Wiesinger, W. Peters, and D. Chappell, Nanomechanics of the endothelial glycocalyx in experimental sepsis, PloS One, vol.8, p.80905, 2013.

T. E. Woodcock and T. M. Woodcock, Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy, British Journal of Anaesthesia, vol.108, pp.384-94, 2012.

W. L. Lee and A. S. Slutsky, Sepsis and endothelial permeability, New England Journal of Medicine, vol.363, pp.689-91, 2010.

D. Payen, A. C. De-pont, Y. Sakr, C. Spies, K. Reinhart et al., A positive fluid balance is associated with a worse outcome in patients with acute renal failure, Critical Care, vol.12, p.74, 2008.

P. E. Marik, Aminoglycoside volume of distribution and illness severity in critically ill septic patients, Anaesthesia and Intensive Care, vol.21, pp.172-175, 1993.

J. A. Roberts, F. S. Taccone, A. A. Udy, J. L. Vincent, F. Jacobs et al., Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens, Antimicrobial Agents and Chemotherapy, vol.55, pp.2704-2713, 2011.

C. Buerger, N. Plock, P. Dehghanyar, C. Joukhadar, and C. Kloft, Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis, Antimicrobial Agents and Chemotherapy, vol.50, pp.2455-63, 2006.

N. M. Mehta, D. R. Halwick, B. L. Dodson, J. E. Thompson, and J. H. Arnold, Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment, Intensive Care Medicine, vol.33, pp.1018-1042, 2007.

J. Sherwin, T. Heath, and K. Watt, Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature, Clinical Therapeutics, vol.38, pp.1976-94, 2016.

K. Donadello, J. A. Roberts, and S. Cristallini, Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study, Critical Care, vol.18, p.632, 2014.

K. Donadello, E. Antonucci, and S. Cristallini, beta-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study, International Journal of Antimicrobial Agents, vol.45, pp.278-82, 2015.

S. Finfer, R. Bellomo, and S. Mcevoy, Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study, British Medical Journal, vol.333, p.1044, 2006.

M. Ulldemolins, J. A. Roberts, J. Rello, D. L. Paterson, and J. Lipman, The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients, Clinical Pharmacokinetics, vol.50, pp.99-110, 2011.

A. Fleck, G. Raines, and F. Hawker, Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury, Lancet, vol.1, pp.781-785, 1985.

C. Verdant, D. Backer, and D. , How monitoring of the microcirculation may help us at the bedside, Current Opinion in Critical Care, vol.11, pp.240-244, 2005.

P. G. Ambrose, S. M. Bhavnani, E. J. Ellis-grosse, and G. L. Drusano, Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap, Clinical Infectious Diseases, vol.51, issue.1, pp.103-113, 2010.

J. A. Roberts, M. S. Roberts, T. A. Robertson, A. J. Dalley, and J. Lipman, Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?, Critical Care Medicine, vol.37, pp.926-959, 2009.

C. Joukhadar, M. Frossard, and B. X. Mayer, Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock, Critical Care Medicine, vol.29, pp.385-91, 2001.

V. Vallon, R. C. Blantz, and S. Thomson, Glomerular hyperfiltration and the salt paradox in early [corrected] type 1 diabetes mellitus: a tubulo-centric view, Journal of the American Society of Nephrology, vol.14, pp.530-537, 2003.

A. Chagnac, T. Weinstein, M. Herman, J. Hirsh, U. Gafter et al., The effects of weight loss on renal function in patients with severe obesity, Journal of the American Society of Nephrology, vol.14, pp.1480-1486, 2003.

R. E. Schmieder, R. Veelken, H. Schobel, P. Dominiak, J. F. Mann et al., Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension, Journal of the American Society of Nephrology, vol.8, pp.893-900, 1997.

P. Moran, P. H. Baylis, M. D. Lindheimer, and J. M. Davison, Glomerular ultrafiltration in normal and preeclamptic pregnancy, Journal of the American Society of Nephrology, vol.14, pp.648-52, 2003.

A. Denic, J. Mathew, and L. O. Lerman, Single-Nephron Glomerular Filtration Rate in Healthy Adults, New England Journal of Medicine, vol.376, pp.2349-57, 2017.

P. Loirat, J. Rohan, A. Baillet, F. Beaufils, R. David et al., Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin, New England Journal of Medicine, vol.299, pp.915-924, 1978.

K. E. Kim, G. Onesti, O. Ramirez, A. N. Brest, and C. Swartz, Creatinine clearance in renal disease. A reappraisal, British Medical Journal, vol.4, pp.11-15, 1969.

M. Carlier, A. Dumoulin, and A. Janssen, Comparison of different equations to assess glomerular filtration in critically ill patients, Intensive care medicine, vol.41, pp.427-462, 2015.

J. J. Dixon, K. Lane, and R. N. Dalton, Validation of a continuous infusion of low dose Iohexol to measure glomerular filtration rate: randomised clinical trial, Journal of Translational Medicine, vol.13, p.58, 2015.

A. A. Udy, P. Jarrett, and J. Stuart, Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C, International Journal of Antimicrobial Agents, vol.18, pp.545-553, 2010.

J. Lipman, S. C. Wallis, and R. J. Boots, Cefepime versus cefpirome: the importance of creatinine clearance, Anesthesia and Analgesia, vol.97, pp.1149-54, 2003.

A. A. Udy, J. M. Varghese, and M. Altukroni, Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations, Chest, vol.142, pp.30-39, 2012.

A. A. Udy, M. T. Putt, R. J. Boots, and J. Lipman, ARC--augmented renal clearance, Current Pharmaceutical Biotechnology, vol.12, pp.2020-2029, 2011.

B. O. Claus, E. A. Hoste, K. Colpaert, H. Robays, J. Decruyenaere et al., Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy, Journal of Critical Care, vol.28, pp.695-700, 2013.

A. Huttner, V. Dach, E. Renzoni, and A. , Augmented renal clearance, low beta-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study, International Journal of Antimicrobial Agents, vol.45, pp.385-92, 2015.

A. A. Udy, J. M. Dulhunty, and J. A. Roberts, Association between augmented renal clearance and clinical outcomes in patients receiving beta-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial, International Journal of Antimicrobial Agents, vol.49, pp.624-654, 2017.

G. Sunder-plassmann and W. H. Horl, A critical appraisal for definition of hyperfiltration, American Journal of Kidney Diseases, vol.43, pp.396-403, 2004.

A. A. Udy, J. P. Baptista, and N. L. Lim, Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations, Critical Care Medicine, vol.42, pp.520-527, 2014.

O. Fuster-lluch, M. Geronimo-pardo, R. Peyro-garcia, and M. Lizan-garcia, Glomerular hyperfiltration and albuminuria in critically ill patients, Anaesthesia and intensive care, vol.36, pp.674-80, 2008.

A. A. Udy, J. A. Roberts, A. F. Shorr, R. J. Boots, and J. Lipman, Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients, Critical Care, vol.17, p.35, 2013.

M. L. Campassi, M. C. Gonzalez, and F. D. Masevicius,

, Revista Brasileira de Terapia Intensiva, vol.26, pp.13-20, 2014.

M. Cecconi, D. Backer, D. Antonelli, and M. , Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine, Intensive Care Medicine, vol.40, pp.1795-815, 2014.

D. Giantomasso, D. May, C. N. Bellomo, and R. , Norepinephrine and vital organ blood flow, Intensive Care Medicine, vol.28, pp.1804-1813, 2002.

V. Fanos and L. Cataldi, Renal transport of antibiotics and nephrotoxicity: a review, Journal of Chemotherapy, vol.13, pp.461-72, 2001.

J. M. Conil, B. Georges, and O. Mimoz, Influence of renal function on trough serum concentrations of piperacillin in intensive care unit patients, Intensive care medicine, vol.32, pp.2063-2069, 2006.

V. Minville, K. Asehnoune, and S. Ruiz, Increased creatinine clearance in polytrauma patients with normal serum creatinine: a retrospective observational study, Critical Care, vol.15, p.49, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00663861

J. P. Baptista, E. Sousa, P. J. Martins, and J. M. Pimentel, Augmented renal clearance in septic patients and implications for vancomycin optimisation, International Journal of Antimicrobial Agents, vol.39, pp.420-423, 2012.

A. Lautrette, T. N. Phan, and L. Ouchchane, High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis, BMC Nephrology, vol.13, p.124, 2012.

V. Grootaert, L. Willems, Y. Debaveye, G. Meyfroidt, and I. Spriet, Augmented renal clearance in the critically ill: how to assess kidney function, Annals of Pharmacotherapy, vol.46, pp.952-961, 2012.

R. Minkute, V. Briedis, R. Steponaviciute, A. Vitkauskiene, and R. Maciulaitis, Augmented renal clearance--an evolving risk factor to consider during the treatment with vancomycin, Journal of Clinical Pharmacy and Therapeutics, vol.38, pp.462-469, 2013.

J. P. Baptista, M. Neves, L. Rodrigues, L. Teixeira, J. Pinho et al., Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients, Journal of Nephrology, vol.27, pp.403-413, 2014.

S. Adnan, S. Ratnam, and S. Kumar, Select critically ill patients at risk of augmented renal clearance: experience in a Malaysian intensive care unit, Anaesthesia and Intensive Care, vol.42, pp.715-737, 2014.

A. A. Udy, J. Lipman, and P. Jarrett, Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?, Critical Care, vol.19, p.28, 2015.

J. J. De-waele, A. Dumoulin, A. Janssen, and E. A. Hoste, Epidemiology of augmented renal clearance in mixed ICU patients, Minerva Anestesiologica, vol.81, pp.1079-85, 2015.

C. C. May, S. Arora, S. E. Parli, J. F. Fraser, M. T. Bastin et al., Augmented Renal Clearance in Patients with Subarachnoid Hemorrhage, Neurocritical Care, vol.23, pp.374-383, 2015.

Y. Kawano, S. Morimoto, and Y. Izutani, Augmented renal clearance in Japanese intensive care unit patients: a prospective study, Journal of Intensive Care, vol.4, p.62, 2016.

A. A. Udy, P. Jarrett, and M. Lassig-smith, Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine Clearance, Journal of Neurotrauma, vol.34, pp.137-181, 2017.

J. L. Vincent, J. Rello, and J. Marshall, International study of the prevalence and outcomes of infection in intensive care units, Journal of the American Medical Association, vol.302, pp.2323-2332, 2009.

J. A. Roberts, S. K. Paul, and M. Akova, DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients, Clinical Infectious Diseases, vol.58, pp.1072-83, 2014.

J. A. Roberts, P. Kruger, D. L. Paterson, and J. Lipman, Antibiotic resistance--what's dosing got to do with it?, Critical Care Medicine, vol.36, pp.2433-2473, 2008.

M. Falcone, A. Russo, M. Venditti, A. Novelli, and M. P. Pai, Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia, Clinical Infectious Diseases, vol.57, pp.1568-76, 2013.

S. A. Zelenitsky, G. K. Harding, S. Sun, K. Ubhi, and R. E. Ariano, Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis, Journal of Antimicrobial Chemotherapy, vol.52, pp.668-74, 2003.

P. S. Mckinnon, J. A. Paladino, and J. J. Schentag, Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections, International Journal of Antimicrobial Agents, vol.31, pp.345-51, 2008.

C. Li, X. Du, J. L. Kuti, and D. P. Nicolau, Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections, Antimicrobial agents and chemotherapy, vol.51, pp.1725-1755, 2007.

A. Forrest, D. E. Nix, C. H. Ballow, T. F. Goss, M. C. Birmingham et al., Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients, Antimicrobial Agents and Chemotherapy, vol.37, pp.1073-81, 1993.

S. Zelenitsky, E. Rubinstein, and R. Ariano, Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock, International Journal of Antimicrobial Agents, vol.41, pp.255-60, 2013.

C. R. Rayner, A. Forrest, A. K. Meagher, M. C. Birmingham, and J. J. Schentag, Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme, Clinical Pharmacokinetics, vol.42, pp.1411-1434, 2003.

C. M. Rubino, S. M. Bhavnani, and A. Forrest, Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia, Antimicrobial Agents and Chemotherapy, vol.56, pp.130-136, 2012.

N. A. Van-lent-evers, R. A. Mathot, W. P. Geus, B. A. Van-hout, and A. A. Vinks, Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a costeffectiveness analysis, Therapeutic Drug Monitoring, vol.21, pp.63-73, 1999.

F. Scaglione, S. Esposito, and S. Leone, Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia, European Respiratory Journal, vol.34, pp.394-400, 2009.

A. E. Muller, N. Punt, and J. W. Mouton, Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia, Journal of Antimicrobial Chemotherapy, vol.68, pp.900-906, 2013.

P. G. Ambrose, D. M. Grasela, T. H. Grasela, J. Passarell, H. B. Mayer et al., Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections, Antimicrobial Agents and Chemotherapy, vol.45, pp.2793-2800, 2001.

P. A. Moise-broder, A. Forrest, M. C. Birmingham, and J. J. Schentag, Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections, Clinical Pharmacokinetics, vol.43, pp.925-967, 2004.

M. N. Martinez, M. G. Papich, and G. L. Drusano, Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target, Antimicrobial Agents and Chemotherapy, vol.56, pp.2795-805, 2012.

J. S. Bertino, Therapeutic drug monitoring of antibiotics, Lancet Infectious Diseases, vol.14, pp.1180-1181, 2014.

J. A. Roberts and J. Lipman, Pharmacokinetic issues for antibiotics in the critically ill patient, Critical Care Medicine, vol.37, pp.840-51, 2009.

E. Ocampos-martinez, L. Penaccini, and S. Scolletta, Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients, International Journal of Antimicrobial Agents, vol.39, pp.332-339, 2012.

M. Carlier, S. Carrette, and J. A. Roberts, Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?, Critical Care, vol.17, p.84, 2013.

B. Georges, J. M. Conil, and T. Seguin, Population pharmacokinetics of ceftazidime in intensive care unit patients: influence of glomerular filtration rate, mechanical ventilation, and reason for admission, Antimicrobial Agents and Chemotherapy, vol.53, pp.4483-4492, 2009.

J. A. Roberts and J. Lipman, Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility, Critical Care Medicine, vol.41, pp.489-95, 2013.

J. P. Burnham, S. T. Micek, and M. H. Kollef, Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials, PloS One, vol.12, p.180247, 2017.

C. Carrie, M. Bentejac, and V. Cottenceau, Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: a preliminary study, Critical Care & Pain Medicine, 2017.

J. A. Kellum and N. Lameire, Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1), Critical Care, vol.17, p.204, 2013.

F. B. Sime, A. A. Udy, and J. A. Roberts, Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization, Current Opinion in Pharmacology, vol.24, pp.1-6, 2015.

J. F. Barletta, A. J. Mangram, and M. Byrne, The importance of empiric antibiotic dosing in critically ill trauma patients: Are we under-dosing based on augmented renal clearance and inaccurate renal clearance estimates?, Journal of Trauma and Acute Care Surgery, vol.81, pp.1115-1136, 2016.

J. W. Pickering, C. M. Frampton, R. J. Walker, G. M. Shaw, and Z. H. Endre, Four hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients, Critical Care, vol.16, p.107, 2012.

J. R. Prowle, Does augmented creatinine clearance accurately reflect glomerular hyperfiltration in critical illness?, Critical Care Medicine, vol.42, pp.674-679, 2014.

O. Pajot, C. Burdet, and C. Couffignal, Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia, The Journal of antimicrobial chemotherapy, vol.70, pp.1487-94, 2015.

J. P. Baptista and A. A. Udy, Augmented renal clearance in critical illness, Minerva Anestesiologica, vol.81, pp.1050-1052, 2015.

D. C. Angus and T. Van-der-poll, Severe sepsis and septic shock, New England Journal of Medicine, vol.369, p.2063, 2013.

R. P. Dellinger, M. M. Levy, and A. Rhodes, Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, Intensive care medicine, vol.39, pp.165-228, 2012.

R. Ferrer, A. Artigas, and D. Suarez, Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study, American Journal of Respiratory and Critical Care Medicine, vol.180, pp.861-867, 2009.

J. Lipman, A. A. Udy, and J. A. Roberts, Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story, Anaesthesia and Intensive Care, vol.39, pp.999-1000, 2011.

R. C. , Diagnostic microbiologique des infections bronchopulmonaires, Société francaise de microbiologie, p.97, 1995.